Dr. Susan Waserman, Principal Investigator, McMaster University (Canada) and other international Co-investigators have collaborated with patient organizations which support individuals with food allergies, to conduct this study to better understand consumer perspectives about epinephrine / adrenaline auto-injectors (EAIs/AAIs) worldwide. An online survey, offered in 12 languages, was completed by almost 8,200 people in 21 countries.

We were pleased that the e-poster of this study was selected from amongst 15 posters that were presented on June 19th at the EAACI 2017 Congress in Helsinki, Finland. Criteria included the quality and usefulness of the research and the presentation itself.

We thank those who supported the study, including Pfizer Canada, Food Allergy Canada (in-kind), EAACI, and the participating patient organizations and their medical advisors who volunteered their time and expertise. We also extend a special thanks to Dr. Antonella Muraro, who has worked hard to ensure that the patient organizations are integrated into EAACI and has encouraged and facilitated allergy-related projects.

To read the abstract that was submitted, click here.
Last updated 19 October 2017
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback